ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.107867T>C (p.Leu35956Pro)

dbSNP: rs267607156
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001378935 SCV001576636 likely pathogenic Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2022-10-13 criteria provided, single submitter clinical testing This missense change has been observed in individuals with clinical features of tibial muscular dystrophy (PMID: 12145747; Invitae). It has also been observed to segregate with disease in related individuals. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant is located in the M band of TTN (PMID: 25589632). Variants in this region may be relevant for neuromuscular disorders, but have not been definitively shown to cause cardiomyopathy (PMID: 23975875). Experimental studies have shown that this missense change affects TTN function (PMID: 25739468). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 12653). This variant is also known as Leu>Pro mutation at position 293357 and L66P. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 35956 of the TTN protein (p.Leu35956Pro).
Revvity Omics, Revvity RCV001781256 SCV002021537 likely pathogenic not provided 2021-04-14 criteria provided, single submitter clinical testing
GeneDx RCV001781256 SCV004035616 likely pathogenic not provided 2023-09-13 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies suggest that when this variant is transfected in E.coli, there is decreased expression compared to wild type, as well as misfolding at all temperatures impairing M10 binding properties (Rudloff et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Located in the M-line region of TTN; Also known as the French variant, L66P, and L33388P; This variant is associated with the following publications: (PMID: 25877298, 27854229, 12145747, 25739468)
OMIM RCV000013489 SCV000033736 pathogenic Tibial muscular dystrophy 2002-09-01 no assertion criteria provided literature only
GeneReviews RCV000013489 SCV000054698 not provided Tibial muscular dystrophy no assertion provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.